Patients characteristics
| Variable | AM n (%) | CQ n (%) | HCQ n (%) | p Value1-150 |
|---|---|---|---|---|
| Sex | ||||
| Female | 719 (77) | 403 (75) | 316 (79) | NS |
| Male | 221 (23) | 136 (25) | 85 (21) | NS |
| Disease duration (y)† mean (SD) | 4.1 (6.6) | 4.0 (6.5) | 4.2 (6.8) | NS |
| Age mean (SD)† | 47 (15.5) | 45.3 (14.8) | 49.2 (16.2) | <0.0001 |
| Drug | ||||
| CQ | 541 (58) | — | — | |
| HCQ | 399 (42) | — | — | |
| Disease | ||||
| RA | 557 (59) | 287 (53) | 270 (68) | <0.0001 |
| SLE | 178 (19) | 113 (21) | 65 (16) | NS |
| PA | 128 (14) | 91 (17) | 37 (9) | <0.001 |
| Other | 77 (8) | 50 (9) | 27 (7) | NS |
| Rank | ||||
| First | 676 (72) | 400 (74) | 276 (69) | <0.05 |
| Other | 264 (28) | 139 (26) | 125 (31) | <0.05 |
| Combination | 174 (19) | 85 (16) | 89 (22) | <0.01 |
↵1-150 CQ v HCQ, †at the onset of AM therapy, NS = not significant.